Works matching AU Bang, Soo-Mee

Results: 96
    1
    2
    3
    4
    5

    Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2995, doi. 10.1007/s00432-021-03872-4
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    6
    7
    8
    9
    10

    Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03197-9
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 1, p. 515, doi. 10.1007/s00277-024-05958-8
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Chim, Chor Sang;
    • Carson, Robin;
    • Liu, Rui;
    • Zhao, Man;
    • Chen, Xi;
    • Cui, Canchan;
    • Hou, Jian;
    • Wang, Jianxiang
    Publication type:
    Article
    21

    Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study.

    Published in:
    2024
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Chim, Chor Sang;
    • Carson, Robin;
    • Liu, Rui;
    • Zhao, Man;
    • Chen, Xi;
    • Cui, Canchan;
    • Hou, Jian;
    • Wang, Jianxiang
    Publication type:
    Correction Notice
    22
    23
    24
    25

    Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.

    Published in:
    Clinical & Translational Gastroenterology, 2018, v. 9, n. 8, p. 1, doi. 10.1038/s41424-018-0043-2
    By:
    • Senzolo, Marco;
    • Riva, Nicoletta;
    • Dentali, Francesco;
    • Rodriguez-Castro, Kryssia;
    • Sartori, Maria Teresa;
    • Bang, Soo-Mee;
    • Martinelli, Ida;
    • Schulman, Sam;
    • Alatri, Adriano;
    • Beyer-Westendorf, Jan;
    • Di Minno, Matteo Nicola Dario;
    • Ageno, Walter
    Publication type:
    Article
    26

    Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 446, doi. 10.1016/j.clml.2023.02.009
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Lin, Tung-Liang;
    • Chim, Chor Sang;
    • Qi, Ming;
    • Wang, Jianping;
    • Lu, Xiaolin;
    • Song, Yang;
    • Jia, Bin;
    • Yang, Xue;
    • Liu, Wenyu;
    • Zhou, Tianyuan
    Publication type:
    Article
    27
    28

    A Prospective, Multicenter Phase II Study of Consolidation with Cyclophosphamide, Bortezomib and Dexamethasone (CVD) in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation; The KMM130 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e291, doi. 10.1016/j.clml.2019.09.478
    By:
    • Eom, Hyeon-Seok;
    • Jung, Jongheon;
    • Kim, Kihyun;
    • Min, Chang Ki;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Lee, Jae Hoon;
    • Kim, Jin Seok;
    • Shin, Ho-Jin;
    • Bang, Soo-Mee;
    • Sohn, Sang Kyun;
    • Suh, Cheolwon
    Publication type:
    Article
    29

    Carfilzomib, Thalidomide and Dexamethasone (KTd) is safe and effective in RRMM: interim analysis of the single arm, multicentre phase II ALLG MM018/AMN002 study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e274, doi. 10.1016/j.clml.2019.09.452
    By:
    • Ninkovic, Slavisa;
    • Chng, Wee Joo;
    • Harrison, Simon J.;
    • Murphy, Nick;
    • Lee, Jae Hoon;
    • Estell, Jane;
    • Horvath, Noemi;
    • Eek, Richard;
    • Augustson, Bradley;
    • Kalro, Akash;
    • Rajagopal, Rajeev;
    • Kim, Kihyun;
    • Bang, Soo-Mee;
    • Huang, Shang-Yi;
    • Butcher, Belinda;
    • Durie, Brian;
    • Mollee, Peter;
    • Quach, Hang
    Publication type:
    Article
    30
    31

    The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e74, doi. 10.1016/j.clml.2017.03.135
    By:
    • Lee, Ho Sup;
    • Min, Chang Ki;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon Seok;
    • Lee, Jae Hoon;
    • Yoon, Do Hyun;
    • Kim, Inho;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Mun, Yeung-Chul;
    • Kim, Hyo Jung;
    • Park, Seong Kyu
    Publication type:
    Article
    32

    Clinical Features and Results of Bortezomib-Melphalan-Prednisone (VMP) as Initial Treatment in Elderly Multiple Myeloma Patients Received Lenalidomide with Dexamethasone (Len/Dex): Subgroup Analysis of Lenalidomide Registry from Korean Multiple Myeloma Working Party (KMM151)

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e129, doi. 10.1016/j.clml.2017.03.233
    By:
    • Jo, Jae-Cheol;
    • Lee, Ho Sup;
    • Min, Chang Ki;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Lee, Jae Hoon;
    • Yoon, Do Hyun;
    • Kim, Inho;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Lim, Sung-Nam;
    • Cho, Su-Hee
    Publication type:
    Article
    33

    The outcomes of Korean Patients With Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e38, doi. 10.1016/j.clml.2017.03.067
    By:
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Yoon, Do Hyun;
    • Min, Chang Ki;
    • Sohn, Sang Kyun;
    • Choi, Chul Won;
    • Lee, Ho Sup;
    • Kim, Hyo Jung;
    • Shin, Ho-Jin;
    • Bang, Soo-Mee;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Yhim, Ho-Young;
    • Kim, Min Kyoung;
    • Jo, Jae-Cheol;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon;
    • Kim, Jin Seok
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).

    Published in:
    2020
    By:
    • Jo, Jae-Cheol;
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    journal article
    45
    46

    Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party.

    Published in:
    Annals of Hematology, 2019, v. 98, n. 1, p. 151, doi. 10.1007/s00277-018-3495-2
    By:
    • Jung, Sung-Hoon;
    • Yang, Deok-Hwan;
    • Kim, Sung-Hyun;
    • Lee, Ji-Hyun;
    • Sohn, Sang Kyun;
    • Song, Ik-Chan;
    • Lee, Hong-ghi;
    • Cheong, Jung-Won;
    • Choi, Yunsuk;
    • Shin, Ho-Jin;
    • Lee, Se-ryeon;
    • Lee, Seok;
    • Yoon, Jae-Ho;
    • Lee, Hyewon;
    • Bang, Soo-Mee;
    • Koh, Youngil;
    • Park, Silvia;
    • Kim, Dae Sik;
    • Yhim, Ho-Young
    Publication type:
    Article
    47
    48
    49
    50